المصدر: PRE-Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis: A Phase I/Ib Platform Trial

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05868226Test

المؤلفون: AstraZeneca

المصدر: BrUOG 413: A Phase II Study of Adjuvant Trastuzumab Deruxtecan (Enhertu) + Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2-Positive Cancers of the Esophagus and Gastroesophageal Junction

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05480384Test

المؤلفون: Odense University Hospital, Aalborg University Hospital, Aarhus University Hospital

المساهمون: Morten Mau-Sørensen, MD PhD

المصدر: HERES Trial: Trastuzumab and Standard Treatment With Chemo- and Immunotherapy as First Line Treatment for HER2 Positive Esophageal Squamous Cell Carcinoma Patients

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05170256Test

المؤلفون: Byondis B.V.

المصدر: ISPY-P1.01: Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer: A Phase I/Ib Trial

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04602117Test

المصدر: A Phase 1/2a, Open-Label, Multi-Center Study Evaluating the Safety and Anti-Tumor Activity of Ex Vivo Expanded, Autologous Natural Killer Cells (SNK01) in Combination With Trastuzumab or Cetuximab in Subjects With Advanced/Metastatic HER2- or EGFR-Expressing Cancers

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04464967Test

المؤلفون: Asan Medical Center

المساهمون: Jin-Hee Ahn, Clinical Professor

المصدر: Prospective Phase II Study to Investigate the Efficacy and Safety of Trastuzumab Biosimilar (Samfenet®) Plus Treatment of Physician's Choice (TPC) in Patients With HER2-positive Unresectable Locally Advanced or Metastatic Solid Tumor

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04215159Test

المصدر: A Phase 1 Study of an Autologous ACTR T Cell Product in Combination With Trastuzumab, a Monoclonal Antibody, in Subjects With HER2-Positive Advanced Malignancies

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03680560Test

Other URLs: https://www.unumrx.comTest/

المساهمون: Changhoon Yoo, Assistant professor

المصدر: The Pilot Study of Trastuzumab in Combination With Gemcitabine Plus Cisplatin for HER2-positive Biliary Tract Cancer

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03613168Test

المصدر: INtegratioN of Trastuzumab, With or Without Pertuzumab, Into periOperatiVe chemotherApy of HER-2 posiTIve stOmach caNcer: the INNOVATION-TRIAL

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02205047Test